Alexandre Chicheportiche

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Prostate Cancer Radioligand Therapy: Beta-labeled Radiopharmaceuticals.

Prostate Cancer Radioligand Therapy: Beta-labeled Radiopharmaceuticals.

Journal: PET clinics
Published: April 28, 2024

Distribution and predictors of F-18-FDG uptake values of non-malignant cervical lymph nodes in pediatric patients.

Distribution and predictors of F-18-FDG uptake values of non-malignant cervical lymph nodes in pediatric patients.

Journal: EJNMMI research
Published: March 05, 2024

Impact of Single-Time-Point Estimates of 177Lu-PRRT Absorbed Doses on Patient Management: Validation of a Trained Multiple-Linear-Regression Model in 159 Patients and 477 Therapy Cycles.

Impact of Single-Time-Point Estimates of 177Lu-PRRT Absorbed Doses on Patient Management: Validation of a Trained Multiple-Linear-Regression Model in 159 Patients and 477 Therapy Cycles.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 23, 2022

Towards accurate 177Lu SPECT activity quantification and standardization using lesion-to-background voxel ratio.

Towards accurate 177Lu SPECT activity quantification and standardization using lesion-to-background voxel ratio.

Journal: EJNMMI physics
Published: September 12, 2022

False Positive Findings of [18F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels.

False Positive Findings of [18F]PSMA-1007 PET/CT in Patients After Radical Prostatectomy with Undetectable Serum PSA Levels.

Journal: Frontiers in surgery
Published: May 14, 2022

Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy.

Quantitative SPECT/CT for Dosimetry of Peptide Receptor Radionuclide Therapy.

Journal: Seminars in nuclear medicine
Published: December 16, 2021

RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMORS - IMPROVEMENTS IN THE PROTOCOL FOR MEASUREMENT OF PATIENT RADIATION EXPOSURE

RADIONUCLIDE THERAPY OF NEUROENDOCRINE TUMORS - IMPROVEMENTS IN THE PROTOCOL FOR MEASUREMENT OF PATIENT RADIATION EXPOSURE

Journal: Harefuah
Published: July 15, 2021

Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis.

Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis.

Journal: EJNMMI research
Published: July 14, 2021

Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study.

Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study.

Journal: EJNMMI physics
Published: April 05, 2021

Lessons Learned from Post-COVID-19 Vaccination PET/CT Studies.

Lessons Learned from Post-COVID-19 Vaccination PET/CT Studies.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 30, 2021

[18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.

[18F]-FDHT PET/CT as a tool for imaging androgen receptor expression in high-grade glioma.

Journal: Neuro-oncology advances
Published: March 19, 2021

Perceptual omission errors in positron emission tomography and computed tomography reporting.

Perceptual omission errors in positron emission tomography and computed tomography reporting.

Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
Published: March 09, 2021
Showing 1-12 of 20

Last Updated: 09/26/2026